Colorectal cancer, malignant (ICD10 C18-C21): combined sexes
Five-year relative survival by HSE area of residence and age at diagnosis (2003-2007 diagnosis period)
|
Five-year relative survival (with 95% confidence interval) by HSE area of residence (2003-2007) |
|||||||||||
|
Age at diagnosis |
Total |
Dublin / |
Dublin / |
South |
West |
||||||
|
|
Mid Leinster |
North East |
|||||||||
|
|
|||||||||||
|
all 15-99 |
57.6% |
59.3% |
58.2% |
57.2% |
55.6% |
||||||
|
(unstandardized) |
(56.0-59.1%) |
(56.2-62.3%) |
(54.7-61.5%) |
(54.3-60.0%) |
(52.4-58.7%) |
||||||
|
|
|||||||||||
|
all 15-99 |
57.0% |
59.1% |
57.4% |
56.6% |
54.6% |
||||||
|
(age-standardized)# |
(53.7-60.2%) |
(52.6-65.1%) |
(50.1-64.3%) |
(50.4-62.4%) |
(47.7-60.9%) |
||||||
|
|
|||||||||||
|
15-44 |
64.0% |
69.6% |
61.7% |
63.3% |
62.5% |
||||||
|
(57.6-69.6%) |
(58.0-78.6%) |
(47.4-73.2%) |
(51.9-72.7%) |
(47.0-74.7%) |
|||||||
|
|
|||||||||||
|
45-54 |
63.1% |
65.6% |
61.7% |
60.4% |
63.8% |
||||||
|
(58.9-66.8%) |
(57.7-72.4%) |
(53.2-69.2%) |
(52.2-67.6%) |
(54.8-71.5%) |
|||||||
|
|
|||||||||||
|
55-64 |
60.5% |
62.6% |
63.4% |
57.1% |
59.8% |
||||||
|
(57.4-63.5%) |
(56.3-68.3%) |
(56.6-69.5%) |
(51.4-62.3%) |
(53.2-65.8%) |
|||||||
|
|
|||||||||||
|
65-74 |
57.1% |
58.0% |
57.0% |
60.0% |
53.5% |
||||||
|
(54.4-59.7%) |
(52.8-62.9%) |
(50.9-62.7%) |
(55.0-64.6%) |
(48.0-58.7%) |
|||||||
|
|
|||||||||||
|
75-99 |
49.8% |
52.2% |
50.3% |
49.6% |
45.8% |
||||||
|
(46.7-53.0%) |
(45.8-58.6%) |
(43.3-57.5%) |
(43.8-55.4%) |
(40.2-51.4%) |
|||||||
|
Footnotes: |
|
|
# Age-standardized figures (presented for the more common cancers) use the standard patient population proposed for this cancer by: |
|
|
Corazziari I., Quinn M. & Capocaccia R. 2004. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40: 2307-2316. |
|
|
(Population weights = age 15-44 x7000, 45-54 x12000, 55-64 x23000, 65-74 x29000, 75-99 x29000) |
|
|
Exclusions (as in EUROCARE): |
|
|
Patients aged <15 or >99 at diagnosis; death-certificate-only (DCO) and autopsy-only cases; second or subsequent malignancies in the same patient |
|
|
(or the less serious of two or more synchronously-diagnosed malignancies); in situ carcinomas and tumours of uncertain behaviour. |
|
|
© National Cancer Registry Ireland 2011 (October 2011) Relative survival statistics for Irish cancer patients |
|